The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam eye study

Transactions of the American Ophthalmological Society

Volumn 104, Issue , 2006, Pages 98-106

  Klein, Ronald ^a   Klein, Barbara E K ^a   Moss, Scot E ^a   Wong, Tien Y ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE DISTRIBUTION; AGED; ANAMNESIS; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DRUG USE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETINOPATHY; RISK FACTOR; STATISTICAL SIGNIFICANCE; STEREORADIOGRAPHY; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; BLOOD GLUCOSE; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CHOLESTEROL; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; WISCONSIN;

EID: 33947709971     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (42)

1. McDonough JJ, Garrison GE, Hames CG. Blood pressure and hypertensive disease among negroes and whites; a study in Evans, County, Georgia. Ann Intern Med 1964;61:208-228.
2. Svardsudd K, Wedel H, Aurell E, et al. Hypertensive eye ground changes. Prevalence, relation to blood pressure and prognostic importance. The study of men born in 1913. Acta Med Scand 1978;204:159-167.
3. Leibowitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980;24:335-610.
4. Klein R. Retinopathy in a population-based study. Trans Am Ophthalmol Soc 1992;90:561-594.
5. Stolk RP, Vingerling JR, de Jong PT, et al. Retinopathy, glucose, and insulin in an elderly population. The Rotterdam Study. Diabetes 1995;44:11-15.
6. Yu T, Mitchell P, Berry G, et al. Retinopathy in older persons without diabetes and its relationship to hypertension. Arch Ophthalmol 1998;116:83-89.
7. Klein R, Sharrett AR, Klein BE, et al. Are retinal arteriolar abnormalities related to atherosclerosis? The Atherosclerosis Risk in Communities Study. Arterioscler Thromb Vasc Biol 2000;20:1644-1650.
8. Sharp PS, Chaturvedi N, Wormald R, et al. Hypertensive retinopathy in Afro-Caribbeans and Europeans. Prevalence and risk factor relationships. Hypertension 1995;25:1322-1325.
9. Leske MC, Wu SY, Hyman L, et al. Diabetic retinopathy in a black population: the Barbados Eye Study. Ophthalmology 1999;106:1893-1899.
10. Klein R, Klein BE, Moss SE, et al. Hypertension and retinopathy, arteriolar narrowing, and arteriovenous nicking in a population. Arch Ophthalmol 1994;112:92-98.
11. Wong TY, Klein R, Couper DJ, et al. Retinal microvascular abnormalities and incident stroke: the Atherosclerosis Risk in Communities Study. Lancet 2001;358:1134-1140.
12. Wong TY, Klein R, Sharrett AR, et al. Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 2002;288:67-74.
13. Wong TY, Klein R, Sharrett AR, et al. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons: The Atherosclerosis Risk in Communities Study. Stroke 2002;33:1487-1492.
14. Wong TY, Klein R, Nieto FJ, et al. Retinal microvascular abnormalities and 10-year cardiovascular mortality: a population-based case-control study. Ophthalmology 2003;110:933-940.
15. Wong TY, Hubbard LD, Klein R, et al. Retinal microvascular abnormalities and blood pressure in older people: The Cardiovascular Health Study. Br J Ophthalmol 2002;86:1007-1013.
16. Tekin O, Cukur S, Uraldi C, et al. Relationship between retinopathy and cognitive impairment among hypertensive subjects. A case-control study in the Ankara-Pursaklar region. Eur Neurol 2004;52:156-161.
17. Wong TY, Rosamond W, Chang PP, et al. Retinopathy and risk of congestive heart failure. JAMA 2005;293:63-69.
18. Nakayama T, Date C, Yokoyama T, et al. A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. Stroke 1997;28:45-52.
19. Wong TY, Mohamed Q, Klein R, et al. Do retinopathy signs in non-diabetic individuals predict the subsequent risk of diabetes? Br J Ophthalmol 2006;90:301-303.
20. Wong TY, Klein R, Sharrett AR, et al. Retinal arteriolar diameter and risk for hypertension. Ann Intern Med 2004;140:248-255.
21. Linton KL, Klein BE, Klein R. The validity of self-reported and surrogate-reported cataract and age-related macular degeneration in the Beaver Dam Eye Study. Am J Epidemiol 1991;134:1438-1446.
22. Klein R, Klein BE, Linton KL, et al. The Beaver Dam Eye Study: visual acuity. Ophthalmology 1991;98:1310-1315.
23. Klein R, Klein BE, Lee KE. Changes in visual acuity in a population. The Beaver Dam Eye Study. Ophthalmology 1996;103:1169-1178.
24. Klein R, Klein BE, Lee KE, et al. Changes in visual acuity in a population over a 10-year period: the Beaver Dam Eye Study. Ophthalmology 2001;108:1757-1766.
25. Klein R, Klein BEK, Lee KE, et al. Changes in visual acuity in a population over a 15-year period. The Beaver Dam Eye Study. Am J Ophthalmol 2006; In Press.
26. Klein R, Klein BE. The Beaver Dam Eye Study. Manual of Operations. US Department of Commerce. Springfield, Va: NTIS Accession No. PB91-149823, 1991.
27. Klein R, Klein BE. The Beaver Dam Eye Study II. Manual of Operations. US Department of Commerce. Springfield, Va: NTIS Accession No. PB95-273827, 1995.
28. Klein R, Davis MD, Magli YL, et al. The Wisconsin age-related maculopathy grading system. US Department of Commerce. Springfield,Va: NTIS Accession No. PB91-184267, 1991.
29. Hypertension Detection and Follow-up Program Cooperative Group. The hypertension detection and follow-up program. Prev Med 1976;5:207-215.
30. Stein MW. D-glucose determination with hexokinase and glucose-6-phosphate dehydrogenases. In: Bergmeyer HC, ed. Methods of Enzymatic Analysis. New York: Academic Press; 1963:177.
31. Klenk DC, Hermanson GT, Krohn RI, et al. Determination of glycosylated hemoglobin by affinity chromatography: comparison with colorimetric and ion-exchange methods, and effects of common interferences. Clin Chem 1982;28:2088-2094.
32. Diabetic Retinopathy Study Research Group. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Invest Ophthalmol Vis Sci 1981;21:210-226.
33. Klein BE, Davis MD, Segal P, et al. Diabetic retinopathy. Assessment of severity and progression. Ophthalmology 1984;91:10-17.
34. Klein R, Klein BE, Magli YL, et al. An alternative method of grading diabetic retinopathy. Ophthalmology 1986;93:1183-1187.
35. SAS Institute Inc. SAS/STAT User's Guide, Version 8. Cary, NC: SAS Institute Inc, 1999.
36. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-481.
37. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 1966;50:163-170.
38. Hosmer DW Jr, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989:238-245.
39. Cugini P, Cruciani F, Turri M, et al. 'Minimal-change hypertensive retinopathy' and 'arterial pre-hypertension,' illustrated via ambulatory blood-pressure monitoring in putatively normotensive subjects. Int Ophthalmol 1998;22:145-149.
40. Wong TY, Barr EL, Tapp RJ, et al. Retinopathy in persons with impaired glucose metabolism: the Australian Diabetes Obesity and Lifestyle (AusDiab) study. Am J Ophthalmol 2005;140:1157-1159.
41. van Leiden HA, Dekker JM, Moll AC, et al. Risk factors for incident retinopathy in a diabetic and nondiabetic population: the Hoorn study. Arch Ophthalmol 2003;121:245-251.
42. Wong TY, Duncan BB, Golden SH, et al. Associations between the metabolic syndrome and retinal microvascular signs: the Atherosclerosis Risk in Communities study. Invest Ophthalmol Vis Sci 2004;45:2949-2954.